The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Abstract
Background & aims Bariatric surgery has been reported to lead to complete resolution of nonalcoholic fatty liver disease (NAFLD) following the sustained weight loss induced in obese patients. We performed a systematic review and meta-analysis to evaluate the effects of bariatric surgery on NAFLD in obese patients. Methods We searched MEDLINE, EMBASE, CENTRAL, and Web of Science databases through May 2018 for studies that compared liver biopsy results before and after bariatric surgery in obese patients. Primary outcomes were biopsy-confirmed resolution of NAFLD and NAFLD activity score. Secondary outcomes were worsening of NAFLD after surgery and liver volume. The Grading of Recommendations, Assessment, Development, and Evidence approach was conducted to assess overall quality of evidence. Results We analyzed data from 32 cohort studies comprising 3093 biopsy specimens. Bariatric surgery resulted in a biopsy-confirmed resolution of steatosis in 66% of patients (95% CI, 56%-75%), inflammation in 50% (95% CI, 35%-64%), ballooning degeneration in 76% (95% CI, 64%-86%), and fibrosis in 40% (95% CI, 29%-51%). Patients' mean NAFLD activity score was reduced significantly after bariatric surgery (mean difference, 2.39; 95% CI, 1.58-3.20; P < .001). However, bariatric surgery resulted in new or worsening features of NAFLD, such as fibrosis, in 12% of patients (95% CI, 5%-20%). The overall Grading of Recommendations, Assessment, Development, and Evidence quality of evidence was very low. Conclusions Through this systematic review and meta-analysis, we found that bariatric surgery leads to complete resolution of NAFLD in obese patients. However, some patients develop new or worsened features of NAFLD. Randomized controlled trials are needed to further examine the therapeutic benefits of bariatric surgery for patients with NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, 12% of patients developed new or worsening liver disease, particularly fibrosis [87].”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [87]
In the citing paper
“The overall NAFLD activity score notably decreased (mean difference − 2.39; 95% CI, − 3.20 to − 1.58; P < 0.001), supporting the capacity of surgery-induced Weight loss to reverse key pathological features of NAFLD.”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [87]
In the citing paper
“A comprehensive systematic review and meta-analysis assessed the histological effects of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in patients, analyzing 3,093 paired liver biopsies from 32 cohort studies. Bariatric surgery was associated with significant improvements in hepatic histology: steatosis resolved in 66% of cases, lobular inflammation in 50%, hepatocellular Ballooni”
From Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan (2025) · cites this paper as [87]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., & Chipponi, J. (2003) · ANZ Journal of Surgery · doi:10.1046/j.1445-2197.2003.02748.x · Cited by 7,603
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Flagged first, then by citations
Research works printed but not linked: 3
- Haskins, 2018, US economic burden of fatty liver disease is $32 billion annually, Bariatric News
- Singh, 2017, Treatment options for alcoholic and non-alcoholic fatty liver, World J Clin Cases, 16, 258
- 2017, GRADEpro GDT, Cochrane Community
Cited by
Sorted by citations
Items 301–371 of 371
Diabetes and Non‐alcoholic Fatty Liver Disease
Mantovani, A., Targher, G., & Byrne, C. D. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch57 · Cited by 1
Sobral, M. V. S., Faria, H. S., Bendaham, L. C. A. R., Masiero, B. B., Gouvêa, C. A., Faria, G. D. S., dos Santos, M. D., Peres, C. D. A. P., Ovileira, L., & Souto, E. (2024) · doi:10.22541/au.171170096.61083292/v1
Nicht alkoholische Fettlebererkrankung (NAFLD) – Ursachen, Diagnostik, Therapie
Rau, M., & Geier, A. (2019) · Gastroenterologie up2date · doi:10.1055/a-0664-6643
El control de calidad: requerimiento esencial en la práctica de la medicina actual
Rakela, J. (2019) · Revista médica de Chile · doi:10.4067/s0034-98872019000800953
Covering the Year in CGH: 2019
Kanwal, F. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.007
Chirurgie bariatrique : bénéfices au-delà du poids et du diabète
Halimi, S., & Andréelli, F. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30209-3
La stéatopathie dysmétabolique
Zampaglione, L., Ferrari, J., & Goossens, N. (2020) · Schweizer Gastroenterologie · doi:10.1007/s43472-020-00018-8
Bariatric Surgery and NASH: A Feasible Option
Castagneto‐Gissey, L., Casella-Mariolo, J. R., & Mingrone, G. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_18
Metabolische Chirurgie, mehr als nur Typ-2-Diabetes
Rühle, A., Bošković, A., Billeter, A., Schwarz, A.-C., & Müller-Stich, B. (2020) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-1267-8215 · Cited by 1
Editorial for “Automated Analysis of Multiparametric MRI / MRE Exams for Prediction of NASH ”
Torkzad, M. R. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27540
De los diversos usos del camaleón
Aliaga, J. V. (2003) · Revista de occidente
Efatmaneshnik, M., & Reidsema, C. (2021) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/432
An algorithm for the management of non-alcoholic fatty liver disease in primary care
Dinani, A. M., Sussman, N., Noureddin, M., Fuchs, M. A., Therapondos, G., Girgrah, N., Diaz, V. F., Mantry, P., Rinella, M. E., Asgharpour, A., et al. (2021) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2021.12.00469
Ananthakrishnan, A. N. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.03.024
Onken, J. E. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.11.013
Bariatric surgery and non-alcoholic fatty liver disease
Julià, H., Benaiges, D., & Pedro‐Botet, J. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.05.009
Impact of Metabolic and Bariatric Surgery on Liver Diseases
Agarwal, L., Chekuri, R., Singla, V., Kumar, A., Shalimar, S., & Aggarwal, S. (2022) · Journal of Bariatric Surgery · doi:10.4103/jbs.jbs_9_22
Hígado graso: una epidemia silente
Ortíz, J. E. P. (2022) · Medicina · doi:10.56050/01205498.2184 · Cited by 1
Mucinski, J. M. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/93980
Prinzipien und Ziele der bariatrischen Chirurgie
Patrzyk, M., Karcz, W. K., Frank, A., & Keßler, W. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-61724-3_100-1
Sánchez, C. N. T. (2022) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/59942
Sanyal, A. J., Muthiah, M. D., & Tan, E. X. X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00029-3
The Correlation between Fetuin-A Levels And Nafld Fibrosis Score (NFS)
Siregar, H. S. (2022) · Sumatera Medical Journal · doi:10.32734/sumej.v5i3.9074
Nonalcoholic fatty liver disease: What comes before and what are the consequences?
Bril, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00017-8
Alvarado‐Tápias, E., Maya‐Miles, D., Albillos, A., Aller, R., Ampuero, J., Andrade, R. J., Arechederra, M., Aspichueta, P., Bañales, J. M., Blas‐García, A., et al. (2024) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2024.502207
Bidares, M., Melali, H., Aziz, M., & Salehi, M. (2024) · Hepatitis Monthly · doi:10.5812/hepatmon-141884
Estimate the Effect of Age Pre and Post Sleeve Gastrectomy on Liver Functions
Al-Amiri, R. M., Кадхум, Х. С., & Али, Ф. М. (2024) · Хирургия Восточная Европа · doi:10.34883/pi.2024.13.1.020
Lean NAFLD: Prevalence, risk factors/pathogenesis, natural history, and treatment
Ito, T., & Takahashi, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99649-5.00001-7
Doença Hepática Esteatótica associada à disfunção metabólica
Gusmao, L. V., Ramos, A. C. R., Remigio, G. C. B., Baiardi, V. C. S., & Gonçalves, B. P. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n4-173
The Modulation of Gut Microbiota by Bariatric Metabolic Surgery and Its Role in NAFLD Treatment
郝, 小. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1482288
Cho, Y., & Jun, D. W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0818
Barajas-Gamboa, J. S., Khan, M. S. I., Gobbo, G. D. D., Rivas, H., Pantoja, J. P., Abril, C. M., Moreno, C., Raza, J., Khan, F., Ghazanfar, R., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5240706/v1
Alvarado‐Tápias, E., Maya‐Miles, D., Albillos, A., Aller, R., Ampuero, J., Andrade, R. J., Arechederra, M., Aspichueta, P., Bañales, J. M., Blas‐García, A., et al. (2024) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2024.502207
Başak, K., Ertuğrul, İ., anıl, G. K., Demir, E., & Demir, D. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07619-1 · Cited by 1
Sood, V., Pandey, S., Kehar, M., Louvet, A., Ramírez-Mejía, M. M., & Méndez‐Sánchez, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_12
Bril, F., Berg, G. A., Barchuk, M., & Nogueira, J. P. (2025) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2025.14.1.69
The significance of metabolism-associated steatotic liver disease and its treatment
Vašura, A., Machytka, E., Bužga, M., Macháčková, J., & Král, J. (2025) · Vnitřní lékařství · doi:10.36290/vnl.2025.005
Williams, D. M., Min, T., Beamish, A. J., & Stephens, J. W. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07810-y
A discourse of non-alcoholic steatohepatitis
Ahmed, M. M. M. (2024) · South African journal of gastroenterology and hepatology. · doi:10.36303/sajgh.0934
Sobral, M. V. S., Faria, H. S., Bendaham, L. C. A. R., Masiero, B. B., Gouvêa, C. A., Faria, G. D. S., dos Santos, M. D., Peres, C. D. A. P., de Oliveira, L. M., & Souto, E. B. (2025) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001868
Elsey, M. K., Beltran, N. M., & Serafine, K. M. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174072
Al-Breedy, A. M., Shaker, M. K., & Elsahhar, M. (2025) · Springer eBooks · doi:10.1007/978-981-96-3894-9_10
Type 2 diabetes and fatty liver disease. Part 2: management
Morris, D. (2025) · Independent Nurse · doi:10.12968/indn.2025.8.12
Pinheiro, M. M., Afonso, M. B., & Rodrigues, C. M. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00003-4
Mocellin, F. S., Neyeloff, J. L., Fogliatto, F. S., Blume, C. A., Bahia, L., & Schaan, B. D. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101497
Post-Bariatric Surgery Liver Injury Assessment Using Circulating Caspase-Cleaved Keratin 18
Suchy, W., Stelmach, A., Szymonowicz, M., & Safranow, K. (2023) · Bulletin of pioneering researches of medical and clinical science · doi:10.51847/eustt6nzua
Endo-hepatology: Bridging the gap between lumen and liver
Abdelhamed, W., & El-Kassas, M. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i46.113145
Farsi, F., Sheidaei, A., Mokhber, S., Setarehdan, S. A., Zamaninour, N., Shahmiri, S. S., & Pazouki, A. (2026) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_555_24
Tou, A. M., & Panganiban, J. A. (2026) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2026.115011
Reversal of Acute Liver Injury Post–Roux-en-Y Gastric Bypass With Total Parenteral Nutrition
Daou, C., Mahmoud, F., Alkhader, D. M., Shatnawei, A., & Raheem, S. A. (2026) · ACG Case Reports Journal · doi:10.14309/crj.0000000000001991
MASLD – Krankheitslast, Herausforderungen und neue Therapeutika
Roeb, E. (2026) · Schweizer Gastroenterologie · doi:10.1007/s43472-026-00189-w
Influence of Heart Function on the Assessment of MASLD Using Indocyanine Green Clearance
Salobir, J., Ranković, B., & Kaliterna, T. P. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08560-1
Implications du microbiote intestinal et de la pectine dans la stéato-hépatite non-alcoolique
Houron, C. (2020) · theses.fr (ABES) · doi:10.70675/282e9d85z4f3dz4f5bz9045zd1ce6da72037
Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
Smati, S. (2019) · theses.fr (ABES) · doi:10.70675/01997f55za990z41e6z96baz8221de2a6281
Contribution des études observationnelles dans la méta-analyse
Cheurfa, C. (2023) · theses.fr (ABES) · doi:10.70675/ecaa782bz76f7z4c43za043ze1d3e0cfbfaa
Williams, T. J., Palmer, A. J., Connor, J. P., Holtmann, G., & Clark, P. J. (2026) · Addiction · doi:10.1111/add.70487
Obesity history exacerbates liver macrophage-mediated fibrosis via IGFBP7.
Soedono, S., Chun, S.-W., Vo, D., Julietta, V., Chang, J., Oh, B.-C., Lumeng, C., & Cho, K. (2026) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168322
Lebererkrankungen als Komplikation des Diabetes mellitus
KAHL, S., & Huttasch, M. (2026) · Info Diabetologie · doi:10.1007/s15034-026-5273-x
Hoffmann, T., Wulff, D., Groß, S., Bajwa, B., Blumenstock, G., Mihaljevic, A. L., Malek, N., & Minn, L. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02882-3
Chouik, Y., Canivet, C. M., Julla, J., Mouillot, T., Parlati, L., Rouland, A., Smati, S., Tramunt, B., Anty, R., Boursier, J., et al. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.06.013
Selection of Patients for Sleeve Gastrectomy. Indications and Contraindications
Pedrique, M. M., Oliveros, A. A., Casanova-Aparicio, A., Carrillo, G. A., Jodrá, V. V., & Ruíz-Tóvar, J. (2026) · Springer eBooks · doi:10.1007/978-3-032-25644-7_2
Weight Loss and Remission of Comorbidities After Sleeve Gastrectomy
Moreno, C. G., & Sanchez‐Gollarte, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-25644-7_14
Lemos, G., Torrinhas, R. S., Pino, J. M. V., Calder, P. C., Heymsfield, S. B., Machado, N. M., & Waitzberg, D. L. (2026) · Journal of Obesity · doi:10.1155/jobe/2335829
Kehar, M., Ramji, A. S., Swain, M., Singer, A. G., IVERS, N., Schaufert, W., Betel, M., Dasgupta, K., Sebastiani, G., & Patel, K. (2026) · Canadian Liver Journal · doi:10.3138/canlivj-2026-9-3-guidelines
From adiposity to multisystem morbidity: the case for weight loss as disease modification
Sattar, N. A., Ferguson, L. D., & Lee, M. M. Y. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00186-5
Ghorbani, Y., Schwenger, K. J. P., Maughan, H., Teterina, A. A., Lou, W., Comelli, E. M., Fischer, S. E., Jackson, T. D., Okrainec, A., & Allard, J. P. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106498
Syed‐Abdul, M. M. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2749643
Reytor-González, C., Román-Galeano, N. M., Gavilanes, D. J., Rossetti, G., Cobellis, L., Pilone, V., Simancas‐Racines, D., & Schiavo, L. (2026) · Obesity Pillars · doi:10.1016/j.obpill.2026.100348
Metadata
- Authors
- Lee, Y., Doumouras, A. G., Yu, J., Brar, K., Banfield, L., Gmora, S., Anvari, M., & Hong, D.
- Affiliations
- McMaster University (CA)
- University of Toronto (CA)
- Corresponding author
- Hong, Dennis
- ORCID
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 17
- Issue
- 6
- Pages
- 1040-1060.e11
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2896985838
- Cited by
- 371
- References
- 70
- Citations by year
- 2026: 28 · 2025: 40 · 2024: 54 · 2023: 44 · 2022: 60 · 2021: 73 · 2020: 46 · 2019: 24
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Gastroenterology and Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- bariatric surgery, non-alcoholic fatty liver disease, obesity, weight loss, liver biopsy, NAFLD activity score, hepatic steatosis, liver fibrosis, liver inflammation, ballooning degeneration, liver volume
- MeSH terms
- Humans, Obesity, Body Mass Index, Bariatric Surgery, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review